A股異動丨漢邦高科漲停 與金運激光戰略合作 推動數字水印技術相關應用
格隆匯10月23日丨漢邦高科(300449.SZ)漲停,報11.63元,成交3.6億元,總市值35億元。漢邦高科昨晚間公告,公司與金運激光(300220.SZ)簽署戰略合作協議。通過雙方的戰略合作,推動實現數字水印技術在IP衍生品版權保護運營上的應用,探索該技術在IP衍生品產生合理價值商業模式的研究開發,增強漢邦高科在版權保護方面的技術水平、商業價值和行業影響力,提升金運激光在IP運營行業的服務能力和打造未來運營IP的核心能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.